Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Elevated IL-8 levels during sickle cell crisis

A J Duits1, J B Schnog, L R Lard

  • 1Department of Internal Medicine, and Red Cross Bloodbank Curaçao, St Elizabeth Hospital Curaçao, Netherlands Antilles. aduits@ibmnet

European Journal of Haematology
|December 17, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Keynote-177 Randomized Controlled Trial of First-line PD-1 Blockade for Microsatellite-High or Mismatch Repair-Deficient Advanced Colorectal Cancer: Potential Consequences of the Cross-Over Trial Design and Related Issues.

Cancer medicine·2026
Same author

A comparison of short-term efficacy and toxicity of 2 glucocorticoid bridging strategies in 2 clinical trials in early rheumatoid and undifferentiated arthritis.

Seminars in arthritis and rheumatism·2025
Same author

Characteristics of professional society oncological drug evaluation in the Netherlands from 2016 to 2020: A retrospective analysis.

Journal of cancer policy·2025
Same author

Design issues with lutetium-177 PSMA-617 registration studies that bias the outcome of the experimental arm reflect an increasing misalignment of contemporary oncology trials with true patient benefit.

BJC reports·2024
Same author

Pharmaceutical Industry Payments to Medical Oncologists in the Netherlands: Trends and Patterns Provided by an Open-Access Transparency Data Set.

JCO oncology practice·2024
Same author

Comparison between 1.5T and 3.0T MRI: both field strengths sensitively detect subclinical inflammation of hand and forefoot in patients with arthralgia.

Scandinavian journal of rheumatology·2021
Same journal

Efficacy, Safety, and Treatment-Delivery Feasibility of Autologous Gene Therapy for Sickle Cell Disease: A Systematic Review With Descriptive Synthesis of Clinical Trials.

European journal of haematology·2026
Same journal

ARHGEF2::JAK2 Fusion Drives Leukemogenesis via CCNB1-Dependent Signaling.

European journal of haematology·2026
Same journal

Light Chain Monoclonal Gammopathy of Undetermined Significance: Diagnosis, Biology, and Clinical Management.

European journal of haematology·2026
Same journal

Multiple Myeloma and the Illusion of the Evidence Pyramid.

European journal of haematology·2026
Same journal

Outsmarting Antigen Escape: Next-Generation CAR T Cell Engineering Strategies for Durable Remissions in Hematologic Malignancies.

European journal of haematology·2026
Same journal

Haploidentical Sibling Donors for Pediatric Patients: The Perfect Mismatch?

European journal of haematology·2026
See all related articles

Interleukin-8 (IL-8) serum levels are significantly elevated in sickle cell disease patients experiencing vaso-occlusive crises. This finding suggests IL-8 plays a crucial role in the initiation or progression of sickle cell crises.

Area of Science:

  • Hematology
  • Immunology
  • Molecular Biology

Background:

  • Sickle cell disease (SCD) involves complex vaso-occlusive processes (VOC).
  • Interactions between sickle red blood cells, endothelium, and leukocytes are key to VOC.
  • Cytokines regulate these cellular interactions, highlighting potential therapeutic targets.

Purpose of the Study:

  • To investigate the role of the neutrophil chemokine, Interleukin-8 (IL-8), in SCD.
  • To measure serum IL-8 levels in SCD patients during vaso-occlusive crisis.
  • To compare IL-8 levels with non-symptomatic SCD patients and healthy controls.

Main Methods:

  • Serum samples were collected from SCD patients (HbSS and HbSC) during vaso-occlusive crisis.
  • Serum samples were also collected from non-symptomatic SCD patients and healthy controls.

Related Experiment Videos

  • Serum IL-8 levels were quantified using immunoassay techniques.

    • Main Results:

    • Significantly elevated serum IL-8 levels were observed in SCD patients during crisis compared to healthy controls.
    • Extremely high IL-8 levels were noted in some patients, irrespective of the crisis-inducing factor.
    • A patient experiencing VOC due to rhGM-CSF treatment also exhibited high IL-8 levels at crisis onset.
    • Non-symptomatic SCD patients had IL-8 levels comparable to healthy controls.

    Conclusions:

    • Interleukin-8 (IL-8) is implicated in the initiation or progression of vaso-occlusive crises in sickle cell disease.
    • Elevated IL-8 levels during crisis suggest its involvement in the underlying pathophysiology.
    • Further research into IL-8's role may reveal new therapeutic strategies for SCD management.